Your browser doesn't support javascript.
loading
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects.
Hetland, Geir; Fagerhol, Magne Kristoffer; Wiedmann, Markus Karl Hermann; Søraas, Arne Vasli Lund; Mirlashari, Mohammad Reza; Nissen-Meyer, Lise Sofie Haug; Istre, Mette Stausland; Holme, Pål Andre; Schultz, Nina Haagenrud.
Afiliação
  • Hetland G; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, 0450 Oslo, Norway.
  • Fagerhol MK; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
  • Wiedmann MKH; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, 0450 Oslo, Norway.
  • Søraas AVL; Department of Neurosurgery, Oslo University Hospital Rikshospitalet, 0424 Oslo, Norway.
  • Mirlashari MR; Department of Microbiology, Oslo University Hospital Rikshospitalet, 0424 Oslo, Norway.
  • Nissen-Meyer LSH; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, 0450 Oslo, Norway.
  • Istre MS; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, 0450 Oslo, Norway.
  • Holme PA; Department of Microbiology, Oslo University Hospital Rikshospitalet, 0424 Oslo, Norway.
  • Schultz NH; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Vaccines (Basel) ; 10(8)2022 Aug 06.
Article em En | MEDLINE | ID: mdl-36016155
ChAdOx1 nCoV-19 vaccination has been associated with the rare side effect; vaccine-induced immune thrombotic thrombocytopenia (VITT). The mechanism of thrombosis in VITT is associated with high levels of neutrophil extracellular traps (NETs). The present study examines whether key markers for NETosis, such as H3-NETs and calprotectin, as well as syndecan-1 for endotheliopathy, can be used as prognostic factors to predict the severity of complications associated with ChAdOx1 vaccination. Five patients with VITT, 10 with prolonged symptoms and cutaneous hemorrhages but without VITT, and 15 with only brief and mild symptoms after the vaccination were examined. Levels of H3-NETs and calprotectin in the vaccinated individuals were markedly increased in VITT patients compared to vaccinees with milder vaccination-associated symptoms, and a strong correlation (r ≥ 0.745, p < 0.001) was found with severity of vaccination side effects. Syndecan-1 levels were also positively correlated (r = 0.590, p < 0.001) in vaccinees to side effects after ChAdOx1 nCoV-19 vaccination. We hypothesize that the inflammatory markers NETs and calprotectin may be used as confirmatory tests in diagnosing VITT.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article